Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Ph. D., Doctorat, Universitat Autònoma de Barcelona (UAB)
Award Date: 1 Jan 1991
Degree, Llicenciat, Universitat Autònoma de Barcelona (UAB)
Award Date: 1 Jan 1984
Fingerprint
Dive into the research topics where Cristian Domingo Ribas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
Papadoppoulos, N., Szefier, S., Bacharier, L. B., Maspero, J. F., Domingo Ribas, C., Fiocchi, A., Lee, J. K. W., Daizadeh, N. S., Lederer, D. J., Hardin, M., Gall, R., Djandji, M., Siddiqui, S., Jacob-Nara, J. A., Deniz, Y. & Rowe, P. J., 2023, In: Allergy: European Journal of Allergy and Clinical Immunology.Research output: Contribution to journal › Article › Research › peer-review
-
Basic Assessment of chronic cough in primary care and referral patients to different specialists.
Domingo Ribas, C., Gonzálvez, J., Dávila, I., del Cuvillo, A., Sánchez-Jareño, M., Cea-Calvo, L. & Naberán Toña, K., 12 May 2023, (Accepted in press) In: Therapeutic Advances in Respiratory Disease.Research output: Contribution to journal › Article › Research › peer-review
-
Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study
Domingo Ribas, C., 2023, (Accepted in press) In: Lung.Research output: Contribution to journal › Article › Research › peer-review
-
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
Jackson, D. J., Bacharier, L. B., Phipatanakul, W., Sher, L., Domingo Ribas, C., Papadopoulos, N. G., Modena, B., Li, N., Changming, K., Mohamed, M. A., Dillon, M., Wolfe, K., Gall, R., Amin, N., Mannent, L. P., Laws, E., Rowe, P. J., Jacob-Nara, J. A., Jacob-Nara, J. A., Deniz, Y., & 3 others, 2023, In: Annals of Allergy, Asthma and Immunology.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Dupilumab Reduces Seasonal Asthma Exacerbations in Patients With Type 2 Uncontrolled, Moderate-to-Severe Asthma
Peters, A., Sagara, H., Corren, J., Domingo Ribas, C., Altincatal, A., Soler, X., Pandit-Abid, N., Crikelair, N., Rowe, P. J., Jacob-Nara, J. A. & Deniz, Y., 2023, (Accepted in press) In: Annals of Allergy, Asthma and Immunology.Research output: Contribution to journal › Article › Research › peer-review